Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2008

01.05.2008 | Article

A first Portuguese epidemiological survey of fungaemia in a university hospital

verfasst von: S. Costa-de-Oliveira, C. Pina-Vaz, D. Mendonça, A. Gonçalves Rodrigues

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

A prospective, observational study was conducted at the biggest Portuguese hospital, aiming to evaluate the epidemiology of bloodstream fungal infection. During a period of 12 months (2004), all yeasts isolated from the blood cultures of patients with fungaemia admitted at a university hospital of Porto were collected. Demographic and clinical data, as well as haematological and biochemical profiles, were registered. Antifungal susceptibility was evaluated. The incidence of fungaemia and nosocomial fungaemia were 2.7 and 2 per 1,000 hospital admissions, respectively. Blood strains from 117 patients were identified. Thirty-five percent of yeast isolates were Candida albicans, followed by C. parapsilosis (25.6%). The mortality rate associated with fungaemia was 39.3%; the highest values were found in patients with C. glabrata and C. tropicalis infection. Seventy-five percent of the fungaemia episodes were nosocomial, with 48% mortality; the main predisposing factors were parenteral nutrition, gastric protection with omeprazole, surgical drainage and the presence of central venous catheters (CVCs). Thrombocytopaenia, urinary catheter, gastrointestinal pathology and nosocomial fungaemia were independently associated with a poor outcome. Antifungal susceptibility testing showed high fluconazole resistance (15%), mostly in C. tropicalis. We observed a high incidence of nosocomial fungaemia with high mortality rates. Important predisposing factors were identified, deserving further investigation. Local surveillance is warranted to monitor the incidence of in vitro antifungal resistance.
Literatur
1.
Zurück zum Zitat Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172–1177CrossRef Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172–1177CrossRef
2.
Zurück zum Zitat Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosupressed patients. Lancet Infect Dis 3:685–702PubMedCrossRef Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosupressed patients. Lancet Infect Dis 3:685–702PubMedCrossRef
3.
Zurück zum Zitat Tortorano AM, Kibbler C, Pemán J, Bernhardt H, Klingspor L, Grillot R (2006) Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359–366PubMedCrossRef Tortorano AM, Kibbler C, Pemán J, Bernhardt H, Klingspor L, Grillot R (2006) Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359–366PubMedCrossRef
4.
Zurück zum Zitat Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW; Cryptococcal Active Surveillance Group (1999) Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 179:449–454PubMedCrossRef Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW; Cryptococcal Active Surveillance Group (1999) Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 179:449–454PubMedCrossRef
5.
Zurück zum Zitat Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519–1527PubMedCrossRef Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519–1527PubMedCrossRef
6.
Zurück zum Zitat Sanglard D, Odds FC (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73–85PubMedCrossRef Sanglard D, Odds FC (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73–85PubMedCrossRef
7.
Zurück zum Zitat Clark TA, Hajjed RA (2002) Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15:569–574PubMed Clark TA, Hajjed RA (2002) Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15:569–574PubMed
8.
Zurück zum Zitat Hospenthal DR, Murray CK, Rinaldi MG (2004) The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis 48:153–160PubMedCrossRef Hospenthal DR, Murray CK, Rinaldi MG (2004) The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis 48:153–160PubMedCrossRef
9.
Zurück zum Zitat Clinical Laboratory Standards Institute (CLSI) (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts, 2nd edn. Approved standard M27-A2. National Committee for Clinical Laboratory Standards (NCCLS), Wayne, Pennsylvania Clinical Laboratory Standards Institute (CLSI) (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts, 2nd edn. Approved standard M27-A2. National Committee for Clinical Laboratory Standards (NCCLS), Wayne, Pennsylvania
10.
Zurück zum Zitat Garner JS, Jarvis WR, Emori TG, Toran TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140PubMedCrossRef Garner JS, Jarvis WR, Emori TG, Toran TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140PubMedCrossRef
11.
Zurück zum Zitat Pittet D, Li N, Woolson RF, Wenzel RP (1997) Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 24:1068–1078PubMedCrossRef Pittet D, Li N, Woolson RF, Wenzel RP (1997) Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 24:1068–1078PubMedCrossRef
12.
Zurück zum Zitat Roberts FJ (1989) Definition of polymicrobial bacteremia. Rev Infect Dis 11:1029–1030PubMed Roberts FJ (1989) Definition of polymicrobial bacteremia. Rev Infect Dis 11:1029–1030PubMed
14.
Zurück zum Zitat Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW (2006) Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 44:819–826PubMedCrossRef Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW (2006) Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 44:819–826PubMedCrossRef
15.
Zurück zum Zitat Pfaller MA, Diekema DJ, Messer SA, Hollis RJ, Jones RN (2003) In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother 47:1068–1071PubMedCrossRef Pfaller MA, Diekema DJ, Messer SA, Hollis RJ, Jones RN (2003) In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother 47:1068–1071PubMedCrossRef
16.
Zurück zum Zitat Amrutkar PP, Rege MD, Chen H, LaRocco MT, Gentry LO, Garey KW (2006) Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection 34:322–327PubMedCrossRef Amrutkar PP, Rege MD, Chen H, LaRocco MT, Gentry LO, Garey KW (2006) Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection 34:322–327PubMedCrossRef
17.
Zurück zum Zitat Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP (1998) National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 31:327–332PubMedCrossRef Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP (1998) National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 31:327–332PubMedCrossRef
18.
Zurück zum Zitat Tortorano AM, Pemán J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Cantón E, Zimmermann K, Seaton S, Grillot R; ECMM Working Group on Candidaemia (2004) Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23:317–322PubMedCrossRef Tortorano AM, Pemán J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Cantón E, Zimmermann K, Seaton S, Grillot R; ECMM Working Group on Candidaemia (2004) Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23:317–322PubMedCrossRef
19.
Zurück zum Zitat Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163PubMedCrossRef Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163PubMedCrossRef
20.
Zurück zum Zitat Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J; Brazilian Network Candidemia Study (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44:2816–2823PubMedCrossRef Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J; Brazilian Network Candidemia Study (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44:2816–2823PubMedCrossRef
21.
Zurück zum Zitat Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, Rumpianesi F, Barchiesi F, Esposito R (2006) Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 12:75–80PubMedCrossRef Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, Rumpianesi F, Barchiesi F, Esposito R (2006) Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 12:75–80PubMedCrossRef
22.
Zurück zum Zitat Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Jonhson EM, Perry JD, Sullivan DJ, Wilson JA (2003) Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 54:18–24PubMedCrossRef Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Jonhson EM, Perry JD, Sullivan DJ, Wilson JA (2003) Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 54:18–24PubMedCrossRef
23.
Zurück zum Zitat Pemán J, Cantón E, Gobernado M; Spanish ECMM Working Group on Candidemia (2005) Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 24:23–30PubMedCrossRef Pemán J, Cantón E, Gobernado M; Spanish ECMM Working Group on Candidemia (2005) Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 24:23–30PubMedCrossRef
24.
Zurück zum Zitat Beck-Sagué C, Jarvis WR; National Nosocomial Infections Surveillance System (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 167:1247–1251PubMed Beck-Sagué C, Jarvis WR; National Nosocomial Infections Surveillance System (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 167:1247–1251PubMed
25.
Zurück zum Zitat Sandven P (2000) Epidemiology of candidemia. Rev Iberoam Micol 17:73–81PubMed Sandven P (2000) Epidemiology of candidemia. Rev Iberoam Micol 17:73–81PubMed
26.
Zurück zum Zitat Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S; Japan invasive Mycosis Surveillance Study Group (2004) National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53:283–289PubMedCrossRef Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S; Japan invasive Mycosis Surveillance Study Group (2004) National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53:283–289PubMedCrossRef
27.
Zurück zum Zitat Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ (2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 44:747–751PubMedCrossRef Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ (2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 44:747–751PubMedCrossRef
28.
Zurück zum Zitat Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Ragel-Frausto MS, Rinaldi MG, Saiman OL, Wiblin RT, Wenzel RP; National Epidemiology of Mycoses Survey (NEMIS) Study Group (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186PubMedCrossRef Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Ragel-Frausto MS, Rinaldi MG, Saiman OL, Wiblin RT, Wenzel RP; National Epidemiology of Mycoses Survey (NEMIS) Study Group (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186PubMedCrossRef
29.
Zurück zum Zitat Chen YC, Chang SC, Luh KT, Hsieh WC (2003) Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrobial Chemother 52:71–77CrossRef Chen YC, Chang SC, Luh KT, Hsieh WC (2003) Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrobial Chemother 52:71–77CrossRef
30.
Zurück zum Zitat Dóczi I, Dósa E, Hajdú E, Nagy E (2002) Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. J Med Microbiol 51:677–681PubMed Dóczi I, Dósa E, Hajdú E, Nagy E (2002) Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. J Med Microbiol 51:677–681PubMed
31.
Zurück zum Zitat Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A (2006) Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 49:134–138PubMedCrossRef Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A (2006) Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 49:134–138PubMedCrossRef
32.
Zurück zum Zitat Cole GT, Halawa AA, Anaissie EJ (1996) The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 22(Suppl 2):S73–S88PubMed Cole GT, Halawa AA, Anaissie EJ (1996) The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 22(Suppl 2):S73–S88PubMed
33.
Zurück zum Zitat Chen TC, Chen YH, Tsai JJ, Peng CF, Lu PL, Chang K, Hsieh HC, Chen TP (2005) Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan. J Microbiol Immunol Infect 38:200–210PubMed Chen TC, Chen YH, Tsai JJ, Peng CF, Lu PL, Chang K, Hsieh HC, Chen TP (2005) Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan. J Microbiol Immunol Infect 38:200–210PubMed
34.
Zurück zum Zitat Ben-Abraham R, Keller N, Teodorovitch N, Barzilai A, Harel R, Barzilay Z, Paret G (2004) Predictors of adverse outcome from candidal infection in a tertiary care hospital. J Infect 49:317–323PubMedCrossRef Ben-Abraham R, Keller N, Teodorovitch N, Barzilai A, Harel R, Barzilay Z, Paret G (2004) Predictors of adverse outcome from candidal infection in a tertiary care hospital. J Infect 49:317–323PubMedCrossRef
35.
Zurück zum Zitat Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678PubMedCrossRef Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678PubMedCrossRef
36.
Zurück zum Zitat Loeffler J, Stevens DA (2003) Antifungal drug resistance. Clin Infect Dis 36(suppl 1):S31–S41PubMedCrossRef Loeffler J, Stevens DA (2003) Antifungal drug resistance. Clin Infect Dis 36(suppl 1):S31–S41PubMedCrossRef
37.
Zurück zum Zitat St-Germain G, Laverdière M, Pelletier R, Bourgault AM, Libman M, Lemieux C, Noël G (2001) Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 39:949–953PubMedCrossRef St-Germain G, Laverdière M, Pelletier R, Bourgault AM, Libman M, Lemieux C, Noël G (2001) Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 39:949–953PubMedCrossRef
38.
Zurück zum Zitat Pina-Vaz C, Rodrigues AG, Costa-de-Oliveira S, Ricardo E, Mårdh PA (2005) Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother 56:678–685PubMedCrossRef Pina-Vaz C, Rodrigues AG, Costa-de-Oliveira S, Ricardo E, Mårdh PA (2005) Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother 56:678–685PubMedCrossRef
39.
Zurück zum Zitat Sanglard D (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5:379–385PubMedCrossRef Sanglard D (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5:379–385PubMedCrossRef
Metadaten
Titel
A first Portuguese epidemiological survey of fungaemia in a university hospital
verfasst von
S. Costa-de-Oliveira
C. Pina-Vaz
D. Mendonça
A. Gonçalves Rodrigues
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0448-4

Weitere Artikel der Ausgabe 5/2008

European Journal of Clinical Microbiology & Infectious Diseases 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.